Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study

Robert L. Ferris, Lisa Licitra, Sophie Wildsmith et al.|Annals of Oncology|2020

Cited by 365